Motif ID: Chd1_Pml
Z-value: 4.415


Transcription factors associated with Chd1_Pml:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Chd1 | ENSMUSG00000023852.7 | Chd1 |
Pml | ENSMUSG00000036986.10 | Pml |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Chd1 | mm10_v2_chr17_+_15704963_15704994 | 0.27 | 9.1e-02 | Click! |
Pml | mm10_v2_chr9_-_58249660_58249672 | -0.08 | 6.3e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.5 | 34.5 | GO:0060466 | activation of meiosis involved in egg activation(GO:0060466) |
9.1 | 27.4 | GO:1904978 | regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
8.7 | 52.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
8.7 | 26.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
8.0 | 16.0 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
7.2 | 7.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
7.1 | 28.4 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
6.4 | 19.2 | GO:0060596 | mammary placode formation(GO:0060596) |
6.3 | 31.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
6.0 | 30.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
5.6 | 5.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
5.1 | 15.4 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
5.0 | 15.0 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
5.0 | 10.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
4.8 | 19.2 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
4.8 | 23.9 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
4.6 | 23.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
4.5 | 9.0 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
4.5 | 13.5 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
4.4 | 39.9 | GO:0097107 | postsynaptic density assembly(GO:0097107) |
4.3 | 13.0 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) |
4.3 | 4.3 | GO:0021747 | cochlear nucleus development(GO:0021747) |
4.2 | 12.7 | GO:0019858 | cytosine metabolic process(GO:0019858) |
4.2 | 4.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
4.2 | 12.6 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
4.1 | 12.3 | GO:0003195 | tricuspid valve formation(GO:0003195) |
4.1 | 4.1 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
4.0 | 59.6 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
4.0 | 23.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
3.8 | 7.7 | GO:0021649 | vestibulocochlear nerve structural organization(GO:0021649) cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) ganglion morphogenesis(GO:0061552) facioacoustic ganglion development(GO:1903375) dorsal root ganglion morphogenesis(GO:1904835) |
3.8 | 30.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
3.8 | 15.0 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
3.7 | 26.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
3.7 | 11.0 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
3.7 | 11.0 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
3.6 | 14.6 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
3.6 | 10.9 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
3.6 | 7.2 | GO:0070671 | response to interleukin-12(GO:0070671) |
3.6 | 32.3 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
3.6 | 17.8 | GO:1901660 | calcium ion export(GO:1901660) |
3.6 | 17.8 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
3.6 | 67.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
3.4 | 10.3 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
3.4 | 13.6 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
3.4 | 23.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
3.4 | 10.1 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
3.3 | 10.0 | GO:0060023 | soft palate development(GO:0060023) |
3.3 | 13.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
3.3 | 9.8 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
3.3 | 13.0 | GO:0021586 | pons maturation(GO:0021586) |
3.2 | 22.7 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
3.2 | 16.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
3.2 | 19.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
3.1 | 25.2 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
3.1 | 6.3 | GO:0097494 | regulation of vesicle size(GO:0097494) |
3.1 | 12.3 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
3.1 | 15.4 | GO:0051012 | microtubule sliding(GO:0051012) |
3.1 | 12.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
3.1 | 12.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
3.0 | 6.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
3.0 | 6.1 | GO:1905075 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
3.0 | 6.0 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
3.0 | 9.0 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
3.0 | 11.8 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.9 | 11.8 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.9 | 14.7 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
2.9 | 2.9 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
2.9 | 29.3 | GO:0046959 | habituation(GO:0046959) |
2.9 | 5.9 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
2.9 | 8.8 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
2.9 | 20.3 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
2.9 | 11.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
2.9 | 26.1 | GO:0071420 | cellular response to histamine(GO:0071420) |
2.9 | 8.7 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
2.9 | 2.9 | GO:0030818 | negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) negative regulation of cAMP biosynthetic process(GO:0030818) |
2.9 | 8.6 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
2.8 | 8.5 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
2.8 | 19.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
2.8 | 8.3 | GO:0007525 | somatic muscle development(GO:0007525) |
2.7 | 19.2 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
2.7 | 5.5 | GO:0070375 | ERK5 cascade(GO:0070375) |
2.7 | 5.4 | GO:0061744 | motor behavior(GO:0061744) |
2.7 | 10.8 | GO:0035937 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
2.7 | 5.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
2.7 | 13.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
2.7 | 2.7 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
2.6 | 10.5 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
2.6 | 18.3 | GO:0007296 | vitellogenesis(GO:0007296) |
2.6 | 26.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
2.6 | 7.7 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
2.6 | 12.8 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
2.5 | 7.6 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
2.5 | 7.6 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
2.5 | 7.6 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
2.5 | 15.0 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
2.5 | 7.5 | GO:0071873 | response to norepinephrine(GO:0071873) |
2.5 | 29.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
2.5 | 7.5 | GO:0046671 | negative regulation of retinal cell programmed cell death(GO:0046671) |
2.5 | 7.4 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
2.5 | 12.3 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
2.4 | 7.3 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
2.4 | 7.3 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
2.4 | 2.4 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
2.4 | 14.4 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
2.4 | 4.8 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
2.4 | 7.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
2.4 | 19.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
2.4 | 9.4 | GO:0045759 | negative regulation of action potential(GO:0045759) |
2.3 | 7.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
2.3 | 32.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
2.3 | 7.0 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
2.3 | 25.6 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
2.3 | 7.0 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
2.3 | 9.3 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
2.3 | 2.3 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
2.3 | 2.3 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
2.3 | 22.9 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
2.3 | 18.2 | GO:0097264 | self proteolysis(GO:0097264) |
2.2 | 9.0 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
2.2 | 4.5 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
2.2 | 2.2 | GO:0071105 | response to interleukin-11(GO:0071105) |
2.2 | 15.5 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
2.2 | 11.0 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
2.2 | 6.6 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
2.2 | 10.9 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
2.2 | 2.2 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
2.2 | 10.9 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
2.2 | 10.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
2.2 | 13.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
2.2 | 15.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
2.2 | 17.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
2.1 | 8.6 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
2.1 | 8.6 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
2.1 | 6.4 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
2.1 | 8.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
2.1 | 2.1 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
2.1 | 6.4 | GO:0021764 | amygdala development(GO:0021764) |
2.1 | 8.5 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
2.1 | 12.8 | GO:0005513 | detection of calcium ion(GO:0005513) |
2.1 | 8.5 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
2.1 | 6.3 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
2.1 | 16.9 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
2.1 | 2.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
2.1 | 8.4 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
2.1 | 12.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
2.0 | 30.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
2.0 | 8.0 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
2.0 | 8.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
2.0 | 5.9 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
2.0 | 15.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
2.0 | 9.8 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
2.0 | 29.3 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
1.9 | 9.6 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
1.9 | 9.6 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
1.9 | 9.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
1.9 | 23.1 | GO:0070842 | aggresome assembly(GO:0070842) |
1.9 | 7.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.9 | 3.8 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
1.9 | 17.0 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.9 | 18.8 | GO:0001709 | cell fate determination(GO:0001709) |
1.9 | 1.9 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
1.9 | 20.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.9 | 11.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.9 | 1.9 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
1.8 | 5.5 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.8 | 29.5 | GO:1903859 | regulation of dendrite extension(GO:1903859) |
1.8 | 16.6 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
1.8 | 5.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
1.8 | 1.8 | GO:0072014 | proximal tubule development(GO:0072014) |
1.8 | 12.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.8 | 3.6 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
1.8 | 10.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
1.8 | 14.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.7 | 3.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
1.7 | 15.7 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.7 | 10.4 | GO:1901911 | diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
1.7 | 6.9 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
1.7 | 1.7 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
1.7 | 24.0 | GO:1990403 | embryonic brain development(GO:1990403) |
1.7 | 3.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
1.7 | 6.8 | GO:0097393 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
1.7 | 3.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
1.7 | 5.1 | GO:0016598 | protein arginylation(GO:0016598) |
1.7 | 5.1 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
1.7 | 8.4 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
1.7 | 8.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.7 | 8.4 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.7 | 3.3 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
1.7 | 6.7 | GO:0055071 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
1.7 | 6.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.7 | 9.9 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
1.7 | 1.7 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
1.6 | 3.3 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
1.6 | 4.9 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
1.6 | 4.9 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
1.6 | 4.9 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.6 | 8.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
1.6 | 6.5 | GO:0061010 | gall bladder development(GO:0061010) |
1.6 | 11.4 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
1.6 | 4.9 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
1.6 | 4.9 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) |
1.6 | 4.9 | GO:0015866 | ADP transport(GO:0015866) |
1.6 | 13.0 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
1.6 | 6.5 | GO:0021604 | cranial nerve structural organization(GO:0021604) |
1.6 | 4.8 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
1.6 | 14.4 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
1.6 | 1.6 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
1.6 | 1.6 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
1.6 | 20.7 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
1.6 | 4.8 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
1.6 | 3.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
1.6 | 1.6 | GO:0003383 | apical constriction(GO:0003383) |
1.6 | 6.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.6 | 4.7 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
1.6 | 62.7 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
1.6 | 4.7 | GO:0035973 | aggrephagy(GO:0035973) |
1.6 | 4.7 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
1.6 | 4.7 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
1.5 | 3.1 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
1.5 | 12.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.5 | 4.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.5 | 1.5 | GO:0065001 | specification of axis polarity(GO:0065001) |
1.5 | 7.7 | GO:0015871 | choline transport(GO:0015871) |
1.5 | 18.3 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
1.5 | 9.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
1.5 | 32.0 | GO:0007413 | axonal fasciculation(GO:0007413) |
1.5 | 4.6 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
1.5 | 21.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
1.5 | 9.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.5 | 1.5 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.5 | 9.0 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
1.5 | 4.5 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
1.5 | 4.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.5 | 1.5 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
1.5 | 4.5 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
1.5 | 7.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.5 | 4.5 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
1.5 | 7.4 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
1.5 | 10.3 | GO:0014850 | response to muscle activity(GO:0014850) |
1.5 | 5.9 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
1.5 | 1.5 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.5 | 13.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
1.4 | 7.2 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
1.4 | 2.9 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
1.4 | 4.3 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.4 | 8.6 | GO:0051013 | microtubule severing(GO:0051013) |
1.4 | 13.0 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
1.4 | 5.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.4 | 8.5 | GO:0016266 | O-glycan processing(GO:0016266) |
1.4 | 10.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.4 | 4.2 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
1.4 | 1.4 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
1.4 | 8.4 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
1.4 | 5.6 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.4 | 5.6 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
1.4 | 4.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
1.4 | 4.2 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
1.4 | 2.8 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
1.4 | 5.5 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
1.4 | 2.8 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
1.4 | 39.9 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
1.4 | 9.6 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
1.4 | 8.2 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
1.4 | 4.1 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
1.4 | 8.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
1.4 | 4.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
1.4 | 9.5 | GO:0030242 | pexophagy(GO:0030242) |
1.3 | 5.4 | GO:0044330 | canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
1.3 | 53.8 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
1.3 | 1.3 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
1.3 | 34.8 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
1.3 | 2.7 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
1.3 | 6.7 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
1.3 | 1.3 | GO:0046958 | nonassociative learning(GO:0046958) |
1.3 | 2.7 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
1.3 | 1.3 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
1.3 | 1.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.3 | 1.3 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
1.3 | 1.3 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
1.3 | 5.2 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
1.3 | 5.2 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
1.3 | 28.4 | GO:0071625 | vocalization behavior(GO:0071625) |
1.3 | 3.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
1.3 | 9.0 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
1.3 | 10.2 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
1.3 | 6.4 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
1.3 | 3.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
1.3 | 2.5 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
1.3 | 2.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
1.3 | 3.8 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
1.3 | 1.3 | GO:1990859 | cellular response to endothelin(GO:1990859) |
1.3 | 11.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
1.3 | 32.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
1.3 | 8.8 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
1.3 | 7.5 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
1.2 | 3.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.2 | 3.7 | GO:0098885 | actin filament bundle distribution(GO:0070650) modification of postsynaptic actin cytoskeleton(GO:0098885) |
1.2 | 8.7 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
1.2 | 5.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
1.2 | 4.9 | GO:0033092 | positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
1.2 | 17.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
1.2 | 3.7 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
1.2 | 3.7 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.2 | 3.7 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
1.2 | 12.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
1.2 | 2.4 | GO:1903978 | regulation of microglial cell activation(GO:1903978) |
1.2 | 2.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.2 | 9.7 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
1.2 | 1.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.2 | 4.9 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
1.2 | 8.5 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.2 | 7.3 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.2 | 16.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.2 | 9.6 | GO:0006477 | protein sulfation(GO:0006477) |
1.2 | 30.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
1.2 | 7.2 | GO:1902741 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
1.2 | 3.6 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
1.2 | 1.2 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
1.2 | 1.2 | GO:1903430 | negative regulation of cell maturation(GO:1903430) |
1.2 | 2.4 | GO:0072053 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
1.2 | 4.7 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.2 | 4.7 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
1.2 | 17.5 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
1.2 | 15.1 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
1.2 | 2.3 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) drug export(GO:0046618) |
1.2 | 3.5 | GO:0045924 | regulation of female receptivity(GO:0045924) |
1.1 | 4.6 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
1.1 | 3.4 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
1.1 | 3.4 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.1 | 6.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
1.1 | 2.3 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
1.1 | 9.1 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
1.1 | 1.1 | GO:0018307 | enzyme active site formation(GO:0018307) |
1.1 | 5.7 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
1.1 | 1.1 | GO:2000830 | vacuolar phosphate transport(GO:0007037) vitamin D3 metabolic process(GO:0070640) positive regulation of parathyroid hormone secretion(GO:2000830) |
1.1 | 10.1 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of RNA export from nucleus(GO:0046831) |
1.1 | 6.7 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.1 | 10.0 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.1 | 1.1 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
1.1 | 2.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
1.1 | 7.8 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
1.1 | 1.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
1.1 | 8.8 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.1 | 2.2 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
1.1 | 3.3 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
1.1 | 5.4 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
1.1 | 4.3 | GO:0016322 | neuron remodeling(GO:0016322) |
1.1 | 5.4 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
1.1 | 3.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
1.1 | 15.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
1.1 | 7.5 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
1.1 | 3.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
1.1 | 1.1 | GO:0003134 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
1.1 | 5.3 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
1.1 | 1.1 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
1.1 | 6.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.1 | 6.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
1.1 | 3.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.1 | 4.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.1 | 1.1 | GO:0034764 | positive regulation of transmembrane transport(GO:0034764) |
1.1 | 6.3 | GO:1903056 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
1.1 | 5.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.1 | 1.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
1.0 | 6.3 | GO:0048102 | autophagic cell death(GO:0048102) |
1.0 | 1.0 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
1.0 | 3.1 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
1.0 | 3.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
1.0 | 12.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
1.0 | 36.9 | GO:2001222 | regulation of neuron migration(GO:2001222) |
1.0 | 3.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
1.0 | 11.2 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
1.0 | 2.0 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
1.0 | 7.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
1.0 | 7.1 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
1.0 | 69.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.0 | 1.0 | GO:0052151 | modulation by symbiont of host apoptotic process(GO:0052150) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) cellular process regulating host cell cycle in response to virus(GO:0060154) |
1.0 | 3.0 | GO:0090148 | membrane fission(GO:0090148) |
1.0 | 4.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.0 | 3.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
1.0 | 3.0 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
1.0 | 14.0 | GO:0006491 | N-glycan processing(GO:0006491) |
1.0 | 7.0 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
1.0 | 1.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
1.0 | 7.0 | GO:0060346 | bone trabecula formation(GO:0060346) |
1.0 | 5.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.0 | 6.9 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
1.0 | 4.0 | GO:0048524 | positive regulation of viral process(GO:0048524) |
1.0 | 2.0 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
1.0 | 1.0 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
1.0 | 2.9 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) retrograde trans-synaptic signaling(GO:0098917) |
1.0 | 2.9 | GO:0002934 | desmosome organization(GO:0002934) |
1.0 | 5.8 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
1.0 | 1.0 | GO:0060003 | copper ion export(GO:0060003) |
1.0 | 1.0 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
1.0 | 3.9 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
1.0 | 1.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.0 | 3.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.0 | 1.9 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.0 | 20.1 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
1.0 | 6.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.9 | 2.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.9 | 3.8 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.9 | 3.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.9 | 1.9 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) |
0.9 | 1.9 | GO:0045176 | apical protein localization(GO:0045176) |
0.9 | 2.8 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.9 | 12.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.9 | 0.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.9 | 11.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.9 | 1.9 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.9 | 0.9 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.9 | 3.7 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.9 | 6.4 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.9 | 8.3 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) |
0.9 | 27.5 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.9 | 8.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.9 | 0.9 | GO:1905165 | peptidyl-aspartic acid modification(GO:0018197) regulation of lysosomal protein catabolic process(GO:1905165) |
0.9 | 10.8 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.9 | 1.8 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.9 | 1.8 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.9 | 8.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.9 | 1.8 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
0.9 | 6.3 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.9 | 1.8 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.9 | 1.8 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.9 | 4.5 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.9 | 2.7 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.9 | 1.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.9 | 12.4 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.9 | 8.8 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.9 | 3.5 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.9 | 4.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.9 | 0.9 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.9 | 0.9 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.9 | 1.7 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.9 | 1.7 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.9 | 16.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.9 | 3.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.9 | 1.7 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.9 | 11.2 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.9 | 1.7 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.9 | 3.4 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
0.9 | 3.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.9 | 6.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.9 | 31.5 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.8 | 1.7 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.8 | 4.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.8 | 3.4 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.8 | 0.8 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.8 | 2.5 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.8 | 6.7 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.8 | 10.0 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.8 | 1.7 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.8 | 0.8 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.8 | 1.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.8 | 30.0 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.8 | 15.7 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.8 | 2.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.8 | 8.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.8 | 2.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.8 | 1.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.8 | 1.6 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.8 | 4.9 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.8 | 4.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.8 | 3.2 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.8 | 0.8 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.8 | 4.8 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.8 | 0.8 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.8 | 2.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.8 | 3.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.8 | 4.0 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.8 | 3.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.8 | 8.6 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.8 | 2.4 | GO:0072554 | blood vessel lumenization(GO:0072554) |
0.8 | 1.6 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.8 | 9.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.8 | 13.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.8 | 3.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.8 | 1.6 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.8 | 6.2 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.8 | 2.3 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.8 | 5.4 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.8 | 1.5 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
0.8 | 0.8 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.8 | 1.5 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
0.8 | 0.8 | GO:0050904 | diapedesis(GO:0050904) |
0.8 | 8.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.8 | 3.9 | GO:0070166 | enamel mineralization(GO:0070166) |
0.8 | 6.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.8 | 6.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.8 | 0.8 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.8 | 8.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.8 | 10.6 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.8 | 6.8 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.8 | 12.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.8 | 99.8 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.7 | 3.7 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.7 | 1.5 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.7 | 6.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.7 | 20.1 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.7 | 4.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.7 | 1.5 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.7 | 0.7 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.7 | 4.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.7 | 3.6 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
0.7 | 0.7 | GO:0036166 | phenotypic switching(GO:0036166) |
0.7 | 2.9 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.7 | 2.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.7 | 2.2 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.7 | 23.0 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.7 | 3.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.7 | 2.1 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.7 | 0.7 | GO:0071317 | cellular response to isoquinoline alkaloid(GO:0071317) |
0.7 | 5.7 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.7 | 4.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.7 | 4.2 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.7 | 8.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.7 | 2.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.7 | 3.5 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.7 | 12.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.7 | 3.5 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.7 | 5.5 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.7 | 1.4 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.7 | 2.1 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
0.7 | 0.7 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.7 | 3.4 | GO:0097178 | ruffle assembly(GO:0097178) |
0.7 | 2.7 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.7 | 8.7 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.7 | 8.0 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.7 | 4.6 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.7 | 3.9 | GO:0051014 | actin filament severing(GO:0051014) |
0.7 | 5.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.7 | 3.9 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.7 | 1.3 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.6 | 6.5 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.6 | 1.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.6 | 1.3 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.6 | 1.3 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.6 | 5.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.6 | 4.5 | GO:1903624 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.6 | 0.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.6 | 1.3 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.6 | 4.5 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.6 | 5.1 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.6 | 5.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.6 | 24.9 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.6 | 1.9 | GO:1901250 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.6 | 1.9 | GO:0030070 | insulin processing(GO:0030070) |
0.6 | 0.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.6 | 2.5 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.6 | 0.6 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
0.6 | 4.4 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.6 | 13.7 | GO:0003016 | respiratory system process(GO:0003016) |
0.6 | 5.0 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.6 | 0.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.6 | 4.9 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.6 | 2.5 | GO:0006497 | protein lipidation(GO:0006497) |
0.6 | 6.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.6 | 0.6 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.6 | 10.4 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.6 | 0.6 | GO:0097186 | amelogenesis(GO:0097186) |
0.6 | 1.8 | GO:0010730 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.6 | 6.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.6 | 4.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.6 | 1.8 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) |
0.6 | 10.8 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.6 | 1.8 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.6 | 1.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.6 | 1.8 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.6 | 1.2 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
0.6 | 7.0 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.6 | 2.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.6 | 1.7 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.6 | 2.3 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.6 | 1.7 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.6 | 1.7 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.6 | 0.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.6 | 4.0 | GO:0080009 | mRNA methylation(GO:0080009) |
0.6 | 5.1 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
0.6 | 0.6 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.6 | 9.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.6 | 1.7 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.6 | 4.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.6 | 5.1 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.6 | 12.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.6 | 2.2 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.6 | 9.5 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.6 | 3.9 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.6 | 1.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.6 | 0.6 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.6 | 3.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.6 | 8.9 | GO:0045116 | protein neddylation(GO:0045116) |
0.6 | 1.7 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.6 | 2.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.6 | 1.7 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.6 | 2.8 | GO:0001842 | neural fold formation(GO:0001842) |
0.6 | 1.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.6 | 5.0 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.6 | 2.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.5 | 0.5 | GO:0003307 | regulation of Wnt signaling pathway involved in heart development(GO:0003307) |
0.5 | 0.5 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.5 | 2.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.5 | 0.5 | GO:0080144 | amino acid homeostasis(GO:0080144) |
0.5 | 1.6 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.5 | 1.1 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.5 | 0.5 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.5 | 2.1 | GO:0097298 | regulation of nucleus size(GO:0097298) |
0.5 | 0.5 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
0.5 | 1.6 | GO:1903044 | protein transport into membrane raft(GO:0032596) protein localization to membrane raft(GO:1903044) |
0.5 | 6.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.5 | 1.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.5 | 0.5 | GO:2000314 | negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.5 | 1.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.5 | 5.2 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.5 | 1.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.5 | 0.5 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.5 | 1.5 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.5 | 4.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.5 | 2.0 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.5 | 2.0 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.5 | 1.0 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) formin-nucleated actin cable assembly(GO:0070649) |
0.5 | 1.5 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.5 | 3.5 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.5 | 2.5 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.5 | 0.5 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.5 | 14.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.5 | 1.5 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.5 | 2.0 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.5 | 1.5 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) |
0.5 | 2.5 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.5 | 2.5 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.5 | 3.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.5 | 0.5 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.5 | 10.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 1.0 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.5 | 1.4 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.5 | 1.0 | GO:0003171 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
0.5 | 2.4 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.5 | 1.4 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.5 | 2.9 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.5 | 6.7 | GO:0060074 | synapse maturation(GO:0060074) |
0.5 | 1.4 | GO:2000318 | T-helper 2 cell activation(GO:0035712) positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
0.5 | 7.1 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.5 | 1.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.5 | 4.7 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.5 | 2.4 | GO:0032303 | regulation of icosanoid secretion(GO:0032303) |
0.5 | 0.9 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.5 | 7.9 | GO:0010842 | retina layer formation(GO:0010842) |
0.5 | 5.6 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.5 | 3.7 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.5 | 4.2 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
0.5 | 25.4 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.5 | 16.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.5 | 2.3 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.5 | 1.4 | GO:0043302 | positive regulation of leukocyte degranulation(GO:0043302) |
0.5 | 1.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.5 | 0.5 | GO:0060702 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
0.5 | 6.8 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.5 | 3.2 | GO:1902305 | regulation of sodium ion transmembrane transport(GO:1902305) |
0.5 | 4.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.4 | 3.6 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.4 | 1.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.4 | 0.9 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.4 | 2.7 | GO:0072666 | establishment of protein localization to vacuole(GO:0072666) |
0.4 | 1.8 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
0.4 | 6.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.4 | 11.5 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.4 | 1.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.4 | 0.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.4 | 2.6 | GO:0006983 | ER overload response(GO:0006983) |
0.4 | 13.2 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.4 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.4 | 6.1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.4 | 8.8 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.4 | 2.6 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.4 | 0.4 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.4 | 0.9 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.4 | 2.2 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.4 | 3.0 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.4 | 1.7 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.4 | 3.0 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
0.4 | 1.3 | GO:0001927 | exocyst assembly(GO:0001927) |
0.4 | 1.3 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
0.4 | 0.9 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.4 | 1.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.4 | 1.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.4 | 2.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.4 | 0.8 | GO:2000836 | positive regulation of androgen secretion(GO:2000836) positive regulation of testosterone secretion(GO:2000845) |
0.4 | 0.8 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
0.4 | 1.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.4 | 2.1 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.4 | 1.2 | GO:0051182 | coenzyme transport(GO:0051182) |
0.4 | 5.3 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.4 | 2.0 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.4 | 0.8 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.4 | 3.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.4 | 6.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.4 | 1.2 | GO:0019085 | early viral transcription(GO:0019085) |
0.4 | 2.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.4 | 27.6 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.4 | 0.8 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.4 | 4.4 | GO:0002021 | response to dietary excess(GO:0002021) |
0.4 | 4.8 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.4 | 1.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.4 | 2.4 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.4 | 2.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.4 | 0.4 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.4 | 0.4 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.4 | 0.4 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.4 | 2.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.4 | 20.3 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.4 | 2.7 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.4 | 2.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 0.4 | GO:0032570 | response to progesterone(GO:0032570) |
0.4 | 1.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.4 | 0.8 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 0.8 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.4 | 1.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.4 | 3.4 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.4 | 1.5 | GO:0042220 | response to cocaine(GO:0042220) |
0.4 | 1.1 | GO:0042196 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.4 | 2.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.4 | 3.8 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.4 | 2.3 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
0.4 | 0.8 | GO:1903912 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.4 | 3.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.4 | 0.7 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.4 | 4.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.4 | 2.2 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.4 | 2.2 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.4 | 1.5 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.4 | 1.8 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.4 | 1.1 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.4 | 2.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.4 | 2.5 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.4 | 1.4 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.4 | 2.5 | GO:0022038 | corpus callosum development(GO:0022038) |
0.4 | 4.6 | GO:0019076 | viral release from host cell(GO:0019076) |
0.4 | 3.9 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.4 | 1.8 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.4 | 9.6 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.4 | 24.4 | GO:0036503 | ERAD pathway(GO:0036503) |
0.4 | 0.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.4 | 1.4 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.4 | 2.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 1.7 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.3 | 0.7 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.3 | 6.6 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.3 | 3.1 | GO:0051693 | actin filament capping(GO:0051693) |
0.3 | 1.7 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.3 | 1.0 | GO:2000110 | protein sialylation(GO:1990743) negative regulation of macrophage apoptotic process(GO:2000110) |
0.3 | 4.8 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.3 | 2.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.3 | 3.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.3 | 0.7 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.3 | 2.0 | GO:0051209 | release of sequestered calcium ion into cytosol(GO:0051209) negative regulation of sequestering of calcium ion(GO:0051283) |
0.3 | 0.3 | GO:0099630 | postsynaptic neurotransmitter receptor cycle(GO:0099630) neurotransmitter receptor transport(GO:0099637) |
0.3 | 3.4 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.3 | 1.7 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.3 | 1.7 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.3 | 1.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.3 | 1.3 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.3 | 32.5 | GO:0006813 | potassium ion transport(GO:0006813) |
0.3 | 1.3 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.3 | 3.0 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.3 | 1.0 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.3 | 1.0 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.3 | 0.7 | GO:0010820 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
0.3 | 0.7 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 0.6 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.3 | 2.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.3 | 22.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.3 | 1.3 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.3 | 0.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.3 | 3.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.3 | 4.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.3 | 0.3 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.3 | 4.7 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.3 | 0.9 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.3 | 0.3 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.3 | 1.2 | GO:0015825 | L-serine transport(GO:0015825) |
0.3 | 1.6 | GO:0031424 | keratinization(GO:0031424) |
0.3 | 0.3 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.3 | 1.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 2.2 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.3 | 6.8 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.3 | 1.8 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 3.3 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 5.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.3 | 1.8 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.3 | 0.6 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.3 | 0.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.3 | 2.1 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.3 | 0.6 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.3 | 2.6 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.3 | 0.3 | GO:0043928 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.3 | 0.6 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.3 | 1.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 0.6 | GO:1903351 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.3 | 4.0 | GO:0044804 | nucleophagy(GO:0044804) |
0.3 | 0.3 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.3 | 1.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 1.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.3 | 3.4 | GO:0006903 | vesicle targeting(GO:0006903) |
0.3 | 1.4 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.3 | 0.3 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.3 | 1.1 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.3 | 4.2 | GO:0048278 | vesicle docking(GO:0048278) |
0.3 | 0.8 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.3 | 0.8 | GO:0015824 | proline transport(GO:0015824) |
0.3 | 0.8 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.3 | 0.8 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.3 | 1.4 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 3.0 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.3 | 0.8 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 24.7 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.3 | 0.3 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.3 | 0.3 | GO:0060013 | righting reflex(GO:0060013) |
0.3 | 4.4 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.3 | 1.6 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.3 | 1.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.3 | 5.4 | GO:0032418 | lysosome localization(GO:0032418) |
0.3 | 0.3 | GO:0030576 | Cajal body organization(GO:0030576) |
0.3 | 4.8 | GO:0045214 | sarcomere organization(GO:0045214) |
0.3 | 0.5 | GO:0034312 | diol biosynthetic process(GO:0034312) |
0.3 | 2.1 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.3 | 0.3 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.3 | 0.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 9.9 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.3 | 0.8 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.3 | 1.8 | GO:0015791 | polyol transport(GO:0015791) |
0.3 | 2.3 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.3 | 0.3 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.3 | 0.8 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.3 | 3.1 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.3 | 1.3 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.3 | 8.9 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.3 | 1.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.3 | 0.8 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.3 | 0.8 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.3 | 2.5 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.3 | 4.0 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.3 | 0.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.3 | 1.5 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.3 | 0.5 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.2 | 4.7 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.2 | 1.5 | GO:0060004 | reflex(GO:0060004) |
0.2 | 1.0 | GO:1903028 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.2 | 1.7 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 0.7 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.2 | 1.4 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.2 | 15.6 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.2 | 8.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.2 | 1.2 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.2 | 1.7 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.7 | GO:0099563 | modification of synaptic structure(GO:0099563) |
0.2 | 3.7 | GO:0030148 | sphingolipid biosynthetic process(GO:0030148) |
0.2 | 0.9 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.2 | 1.8 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 1.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 2.5 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.2 | 1.6 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.2 | 1.1 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 4.0 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.4 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 0.4 | GO:1902592 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.2 | 0.2 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 1.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 3.8 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.2 | 1.5 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 0.8 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.2 | 1.0 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.2 | 1.0 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.2 | 0.6 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
0.2 | 0.2 | GO:1902837 | amino acid import across plasma membrane(GO:0089718) amino acid import into cell(GO:1902837) |
0.2 | 2.2 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.2 | 0.4 | GO:0070417 | cellular response to cold(GO:0070417) |
0.2 | 0.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.8 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.2 | 0.8 | GO:0042044 | fluid transport(GO:0042044) |
0.2 | 0.8 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.2 | 1.0 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 1.4 | GO:0098707 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.2 | 2.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 1.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 1.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.2 | 1.0 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 1.7 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.2 | 0.9 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.2 | 0.6 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 0.8 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
0.2 | 1.1 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.2 | 0.4 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
0.2 | 0.4 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.2 | 2.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 1.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 2.0 | GO:0060079 | excitatory postsynaptic potential(GO:0060079) |
0.2 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.2 | 1.1 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.2 | 1.8 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.2 | 0.5 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.2 | 0.5 | GO:0070384 | Harderian gland development(GO:0070384) |
0.2 | 0.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.5 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 1.9 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 0.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.2 | 0.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 2.0 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 1.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 3.0 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.2 | 0.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 2.0 | GO:1903573 | negative regulation of response to endoplasmic reticulum stress(GO:1903573) |
0.2 | 0.2 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.2 | 1.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 0.6 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 1.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.2 | 0.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.2 | 0.2 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.2 | 0.8 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 1.2 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.2 | 1.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.2 | 0.3 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.2 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.5 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.1 | 0.7 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 1.6 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 1.5 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.6 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 1.0 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.3 | GO:0009597 | detection of virus(GO:0009597) |
0.1 | 0.9 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.1 | 0.4 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 9.7 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 3.1 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.4 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 1.5 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 2.2 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.4 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 0.7 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.5 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 2.5 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 1.0 | GO:0036296 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) |
0.1 | 0.6 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.1 | 0.8 | GO:0032196 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
0.1 | 1.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 3.5 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.1 | 0.5 | GO:1902224 | cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
0.1 | 0.4 | GO:0030432 | phasic smooth muscle contraction(GO:0014821) peristalsis(GO:0030432) |
0.1 | 0.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.6 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 1.3 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.5 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 0.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.4 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.1 | 0.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.5 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.1 | 0.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.5 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 | 1.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.3 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.1 | 0.2 | GO:0002922 | positive regulation of humoral immune response(GO:0002922) |
0.1 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 2.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.3 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 1.3 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 1.5 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 0.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.3 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.1 | 0.4 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.1 | 0.5 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.1 | 1.2 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 1.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 3.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.1 | GO:0071697 | ectodermal placode formation(GO:0060788) ectodermal placode morphogenesis(GO:0071697) |
0.1 | 0.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.4 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.3 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 1.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 2.8 | GO:0031333 | negative regulation of protein complex assembly(GO:0031333) |
0.1 | 0.4 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.1 | 0.3 | GO:0034035 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.3 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.3 | GO:0097484 | dendrite extension(GO:0097484) |
0.1 | 0.3 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.1 | 0.4 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 1.1 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.1 | 1.0 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.1 | 0.4 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.1 | 0.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.6 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.1 | 0.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 0.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 1.2 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.2 | GO:0006788 | heme oxidation(GO:0006788) |
0.1 | 0.2 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.5 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.1 | 0.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 0.3 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.1 | 0.6 | GO:0006560 | proline metabolic process(GO:0006560) |
0.1 | 0.8 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.3 | GO:0002188 | translation reinitiation(GO:0002188) |
0.1 | 0.8 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.4 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.2 | GO:0031627 | telomeric loop formation(GO:0031627) telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.2 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.5 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 1.0 | GO:0048821 | erythrocyte development(GO:0048821) |
0.1 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.4 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 0.2 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.1 | 0.5 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.2 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 0.2 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.1 | 0.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.7 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.4 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.0 | 0.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 1.2 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
0.0 | 0.4 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.0 | 0.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.6 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.0 | 0.1 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.0 | 0.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.1 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.0 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.1 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.0 | 0.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.0 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.0 | 0.1 | GO:0007625 | grooming behavior(GO:0007625) |
0.0 | 0.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.1 | GO:1902003 | regulation of beta-amyloid formation(GO:1902003) |
0.0 | 0.1 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 | 0.1 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
0.0 | 0.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.2 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.1 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.0 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.1 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.1 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.4 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.0 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.0 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 0.0 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.0 | 0.5 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.1 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.0 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.0 | 0.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
0.0 | 0.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.6 | 28.9 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
8.9 | 53.3 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
7.5 | 22.4 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
6.3 | 18.8 | GO:0098855 | HCN channel complex(GO:0098855) |
6.0 | 29.8 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
4.6 | 4.6 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
4.2 | 12.5 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
4.1 | 40.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
4.0 | 15.9 | GO:0060187 | cell pole(GO:0060187) |
3.7 | 11.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
3.7 | 22.4 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
3.6 | 10.9 | GO:0048179 | activin receptor complex(GO:0048179) |
3.5 | 17.5 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
3.4 | 20.6 | GO:0008091 | spectrin(GO:0008091) |
3.4 | 13.7 | GO:0044307 | dendritic branch(GO:0044307) |
3.4 | 20.1 | GO:0005955 | calcineurin complex(GO:0005955) |
3.2 | 9.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
3.2 | 15.9 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
3.2 | 101.3 | GO:0043194 | axon initial segment(GO:0043194) |
3.0 | 38.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
2.9 | 8.8 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
2.7 | 26.9 | GO:0045298 | tubulin complex(GO:0045298) |
2.5 | 7.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
2.5 | 9.9 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
2.5 | 100.7 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
2.4 | 76.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
2.3 | 6.9 | GO:0044194 | cytolytic granule(GO:0044194) |
2.2 | 22.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
2.2 | 15.2 | GO:0070695 | FHF complex(GO:0070695) |
2.2 | 2.2 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
2.1 | 30.0 | GO:1902710 | GABA receptor complex(GO:1902710) |
2.1 | 10.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
2.1 | 2.1 | GO:0000938 | GARP complex(GO:0000938) |
2.1 | 8.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
2.1 | 25.0 | GO:0044666 | MLL3/4 complex(GO:0044666) |
2.1 | 86.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
2.0 | 36.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
2.0 | 22.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
2.0 | 25.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.9 | 7.8 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.9 | 5.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.9 | 1.9 | GO:0044305 | calyx of Held(GO:0044305) |
1.8 | 18.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
1.8 | 5.5 | GO:0032437 | cuticular plate(GO:0032437) |
1.8 | 7.2 | GO:0090537 | CERF complex(GO:0090537) |
1.8 | 5.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
1.8 | 5.3 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.7 | 22.7 | GO:0031209 | SCAR complex(GO:0031209) |
1.7 | 6.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.7 | 6.8 | GO:1990421 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
1.7 | 6.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.7 | 5.1 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
1.7 | 3.4 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
1.7 | 3.4 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.7 | 45.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.7 | 14.9 | GO:0005883 | neurofilament(GO:0005883) |
1.7 | 31.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.6 | 14.8 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.6 | 8.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.6 | 23.7 | GO:0031143 | pseudopodium(GO:0031143) |
1.6 | 7.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.5 | 9.2 | GO:0000322 | storage vacuole(GO:0000322) |
1.5 | 4.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.5 | 4.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
1.5 | 8.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.4 | 4.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.4 | 11.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.4 | 30.1 | GO:0030673 | axolemma(GO:0030673) |
1.4 | 12.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
1.4 | 1.4 | GO:0005683 | U7 snRNP(GO:0005683) |
1.4 | 19.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.4 | 11.3 | GO:0097413 | Lewy body(GO:0097413) |
1.4 | 11.0 | GO:0042382 | paraspeckles(GO:0042382) |
1.4 | 20.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.3 | 5.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.3 | 14.5 | GO:0034704 | calcium channel complex(GO:0034704) |
1.3 | 3.9 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.2 | 3.7 | GO:0031417 | NatC complex(GO:0031417) |
1.2 | 109.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
1.2 | 10.9 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
1.2 | 8.4 | GO:0005827 | polar microtubule(GO:0005827) |
1.2 | 7.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
1.2 | 3.5 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
1.2 | 4.7 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.2 | 2.3 | GO:0070847 | core mediator complex(GO:0070847) |
1.2 | 2.3 | GO:0044327 | dendritic spine head(GO:0044327) |
1.1 | 3.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.1 | 6.9 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
1.1 | 11.3 | GO:0043083 | synaptic cleft(GO:0043083) |
1.1 | 1.1 | GO:0016939 | kinesin II complex(GO:0016939) |
1.1 | 10.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.1 | 3.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
1.1 | 14.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.1 | 11.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.1 | 62.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.1 | 2.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.1 | 4.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.1 | 1.1 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
1.1 | 8.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
1.1 | 5.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.1 | 4.2 | GO:0044308 | axonal spine(GO:0044308) |
1.0 | 10.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.0 | 2.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
1.0 | 24.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.0 | 1.0 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) clathrin-coated endocytic vesicle membrane(GO:0030669) |
1.0 | 6.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
1.0 | 15.1 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
1.0 | 20.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.0 | 284.0 | GO:0099572 | postsynaptic specialization(GO:0099572) |
1.0 | 1.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
1.0 | 8.7 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.9 | 1.9 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.9 | 2.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.9 | 1.8 | GO:0030870 | Mre11 complex(GO:0030870) |
0.9 | 0.9 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.9 | 3.5 | GO:0030891 | VCB complex(GO:0030891) |
0.9 | 2.6 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.9 | 2.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.8 | 12.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.8 | 7.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.8 | 3.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.8 | 2.5 | GO:0005940 | septin ring(GO:0005940) |
0.8 | 42.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.8 | 4.0 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.8 | 16.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.8 | 1.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.8 | 14.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.8 | 2.3 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.8 | 1.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) UBC13-MMS2 complex(GO:0031372) |
0.8 | 1.5 | GO:0044753 | amphisome(GO:0044753) |
0.8 | 3.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.8 | 12.9 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.7 | 5.1 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.7 | 5.0 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.7 | 42.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.7 | 11.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.7 | 7.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.7 | 11.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.7 | 4.2 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.7 | 2.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.7 | 18.3 | GO:1990752 | microtubule plus-end(GO:0035371) microtubule end(GO:1990752) |
0.7 | 1.4 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.7 | 7.0 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.7 | 3.5 | GO:0000235 | astral microtubule(GO:0000235) |
0.7 | 10.9 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.7 | 5.5 | GO:0043196 | varicosity(GO:0043196) |
0.7 | 2.7 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.7 | 2.0 | GO:0031251 | PAN complex(GO:0031251) |
0.7 | 4.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.7 | 1.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.7 | 1.3 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.7 | 2.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.7 | 2.6 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.7 | 30.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.6 | 2.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.6 | 6.5 | GO:0032982 | myosin filament(GO:0032982) |
0.6 | 12.3 | GO:0097228 | sperm principal piece(GO:0097228) |
0.6 | 17.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.6 | 2.5 | GO:0043293 | apoptosome(GO:0043293) |
0.6 | 1.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.6 | 0.6 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.6 | 4.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.6 | 3.7 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.6 | 28.6 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.6 | 6.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.6 | 5.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.6 | 8.4 | GO:0070938 | contractile ring(GO:0070938) |
0.6 | 16.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.6 | 13.7 | GO:0071565 | nBAF complex(GO:0071565) |
0.6 | 2.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.6 | 5.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.6 | 1.2 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.6 | 1.8 | GO:0033268 | node of Ranvier(GO:0033268) |
0.6 | 8.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.6 | 1.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.6 | 1.7 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.6 | 10.5 | GO:0010369 | chromocenter(GO:0010369) |
0.6 | 2.9 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
0.6 | 1.7 | GO:0071920 | cleavage body(GO:0071920) |
0.6 | 7.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.6 | 5.6 | GO:0001739 | sex chromatin(GO:0001739) |
0.6 | 21.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.6 | 20.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.6 | 1.7 | GO:0071439 | clathrin complex(GO:0071439) |
0.6 | 33.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.6 | 4.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.5 | 2.7 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.5 | 12.1 | GO:0002102 | podosome(GO:0002102) |
0.5 | 3.7 | GO:0071203 | WASH complex(GO:0071203) |
0.5 | 43.9 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.5 | 7.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 20.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.5 | 4.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.5 | 118.1 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.5 | 0.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.5 | 1.4 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.5 | 1.0 | GO:0034657 | GID complex(GO:0034657) |
0.5 | 2.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.5 | 6.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.5 | 10.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.5 | 5.6 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.5 | 3.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.5 | 17.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.5 | 42.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.5 | 0.5 | GO:0002141 | stereocilia ankle link(GO:0002141) |
0.5 | 3.6 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.5 | 3.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 37.3 | GO:0016605 | PML body(GO:0016605) |
0.4 | 27.3 | GO:0043204 | perikaryon(GO:0043204) |
0.4 | 0.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.4 | 1.3 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.4 | 0.9 | GO:0043512 | inhibin A complex(GO:0043512) |
0.4 | 7.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.4 | 2.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.4 | 3.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 6.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.4 | 9.6 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.4 | 8.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.4 | 3.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.4 | 37.2 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.4 | 9.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.4 | 2.0 | GO:0032433 | filopodium tip(GO:0032433) |
0.4 | 0.8 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.4 | 3.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.4 | 5.9 | GO:0030008 | TRAPP complex(GO:0030008) |
0.4 | 7.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 2.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.4 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.4 | 1.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.4 | 1.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.4 | 3.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 1.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.4 | 1.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.4 | 1.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.4 | 2.2 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.4 | 1.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.4 | 1.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.4 | 0.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.3 | 2.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 4.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 2.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.3 | 70.0 | GO:0000139 | Golgi membrane(GO:0000139) |
0.3 | 0.7 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.3 | 11.0 | GO:0032420 | stereocilium(GO:0032420) |
0.3 | 2.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 2.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 1.0 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.3 | 1.7 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.3 | 3.6 | GO:0060170 | ciliary membrane(GO:0060170) |
0.3 | 2.0 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.3 | 9.7 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.3 | 6.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.3 | 3.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 27.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 8.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.3 | 7.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.3 | 7.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.3 | 145.6 | GO:0005768 | endosome(GO:0005768) |
0.3 | 2.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.3 | 0.9 | GO:0031533 | mRNA cap methyltransferase complex(GO:0031533) |
0.3 | 12.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.3 | 3.0 | GO:0090544 | BAF-type complex(GO:0090544) |
0.3 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.3 | 2.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 5.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.3 | 0.8 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.3 | 0.8 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 0.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.3 | 9.1 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.3 | 20.1 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.3 | 1.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.3 | 3.2 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 4.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 1.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.3 | 0.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 2.7 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 1.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 3.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 1.5 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 0.7 | GO:0018444 | translation release factor complex(GO:0018444) |
0.2 | 0.2 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.2 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 0.7 | GO:0070985 | TFIIK complex(GO:0070985) |
0.2 | 6.5 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.2 | 1.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 0.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 4.4 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 22.2 | GO:0030427 | site of polarized growth(GO:0030427) |
0.2 | 0.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 7.9 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 2.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 52.2 | GO:0031410 | cytoplasmic vesicle(GO:0031410) |
0.2 | 12.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.2 | 0.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 0.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.2 | 1.0 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 0.4 | GO:0033185 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 5.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 2.1 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.2 | 2.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 1.1 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 18.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 9.8 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.2 | 0.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 4.9 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 7.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 0.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.7 | GO:0097447 | dendritic tree(GO:0097447) |
0.2 | 3.2 | GO:0005903 | brush border(GO:0005903) cluster of actin-based cell projections(GO:0098862) |
0.2 | 1.7 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 0.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 0.6 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 4.6 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 3.0 | GO:0030018 | Z disc(GO:0030018) |
0.2 | 2.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 1.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 1.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 3.9 | GO:0030496 | midbody(GO:0030496) |
0.1 | 5.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 1.8 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 28.2 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 0.4 | GO:0097433 | dense body(GO:0097433) |
0.1 | 5.1 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 1.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 1.7 | GO:0031672 | A band(GO:0031672) |
0.1 | 4.2 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 10.9 | GO:0005773 | vacuole(GO:0005773) |
0.1 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 355.8 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 3.0 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 1.0 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.5 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 3.6 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 1.0 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 3.0 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 0.5 | GO:0097361 | CIA complex(GO:0097361) |
0.1 | 7.5 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 4.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 3.0 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 3.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 1.9 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 1.6 | GO:0072686 | mitotic spindle(GO:0072686) |
0.1 | 1.9 | GO:0019867 | outer membrane(GO:0019867) organelle outer membrane(GO:0031968) |
0.1 | 0.3 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 1.2 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 0.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 1.0 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.5 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.0 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.0 | 0.3 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 1.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.3 | 33.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
7.4 | 29.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
6.9 | 20.7 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
6.2 | 31.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
5.8 | 17.4 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
5.6 | 16.9 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
5.1 | 30.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
5.0 | 35.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
5.0 | 15.0 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
5.0 | 19.8 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
4.9 | 29.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
4.5 | 13.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
4.3 | 30.4 | GO:0099609 | microtubule lateral binding(GO:0099609) |
4.3 | 17.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
4.3 | 38.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
4.2 | 46.6 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
4.2 | 20.9 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
4.0 | 28.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
3.8 | 15.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
3.6 | 14.4 | GO:0038025 | reelin receptor activity(GO:0038025) |
3.6 | 18.0 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
3.5 | 10.6 | GO:0019002 | GMP binding(GO:0019002) |
3.5 | 13.9 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
3.5 | 13.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
3.4 | 13.6 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
3.4 | 20.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
3.4 | 54.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
3.3 | 3.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
3.3 | 9.8 | GO:0031208 | POZ domain binding(GO:0031208) |
3.2 | 9.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
3.2 | 19.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
3.1 | 12.5 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
3.1 | 12.4 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
2.9 | 8.8 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
2.9 | 17.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
2.9 | 17.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
2.9 | 14.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
2.9 | 8.6 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
2.7 | 8.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
2.7 | 13.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.7 | 10.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
2.6 | 23.8 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
2.6 | 7.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
2.6 | 2.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
2.6 | 35.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
2.5 | 28.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
2.5 | 10.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
2.5 | 7.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
2.4 | 19.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.4 | 9.4 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
2.3 | 18.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
2.3 | 13.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
2.3 | 16.0 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
2.3 | 6.8 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
2.2 | 8.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
2.2 | 39.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
2.2 | 6.6 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
2.2 | 10.9 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
2.2 | 10.9 | GO:0004359 | glutaminase activity(GO:0004359) |
2.2 | 15.2 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
2.2 | 17.4 | GO:0046790 | virion binding(GO:0046790) |
2.2 | 13.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
2.1 | 29.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
2.1 | 6.3 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
2.1 | 59.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
2.1 | 8.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
2.1 | 6.2 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
2.0 | 12.2 | GO:0097001 | ceramide binding(GO:0097001) |
2.0 | 15.9 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
2.0 | 9.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
2.0 | 7.8 | GO:0036033 | mediator complex binding(GO:0036033) |
2.0 | 11.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.9 | 13.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.9 | 42.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
1.9 | 24.1 | GO:0031005 | filamin binding(GO:0031005) |
1.9 | 9.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
1.8 | 44.3 | GO:0043274 | phospholipase binding(GO:0043274) |
1.8 | 18.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
1.8 | 11.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.8 | 30.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.8 | 7.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
1.8 | 12.5 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
1.8 | 5.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.8 | 7.0 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
1.8 | 10.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.7 | 1.7 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
1.7 | 10.4 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
1.7 | 3.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.7 | 3.5 | GO:0052744 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
1.7 | 1.7 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
1.7 | 10.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.7 | 6.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.7 | 17.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.7 | 20.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
1.7 | 3.4 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
1.7 | 13.4 | GO:0048495 | Roundabout binding(GO:0048495) |
1.7 | 11.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.7 | 3.3 | GO:1904315 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
1.6 | 22.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.6 | 4.9 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
1.6 | 6.5 | GO:0001847 | opsonin receptor activity(GO:0001847) |
1.6 | 80.3 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
1.6 | 14.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.6 | 19.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
1.6 | 10.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.5 | 9.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
1.5 | 59.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
1.5 | 15.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.5 | 3.0 | GO:0001729 | ceramide kinase activity(GO:0001729) |
1.5 | 4.5 | GO:0070615 | nucleosome-dependent ATPase activity(GO:0070615) |
1.5 | 7.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.5 | 19.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.5 | 4.5 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
1.5 | 5.9 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
1.4 | 4.3 | GO:0035500 | MH2 domain binding(GO:0035500) |
1.4 | 8.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.4 | 4.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
1.4 | 8.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.4 | 8.5 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.4 | 11.2 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
1.4 | 13.9 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
1.4 | 33.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
1.4 | 9.7 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
1.4 | 8.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
1.4 | 23.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
1.3 | 4.0 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
1.3 | 14.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.3 | 25.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
1.3 | 4.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
1.3 | 7.9 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
1.3 | 3.9 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.3 | 8.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.3 | 21.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
1.3 | 5.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
1.3 | 6.3 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
1.2 | 7.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
1.2 | 2.4 | GO:0048185 | activin binding(GO:0048185) |
1.2 | 3.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.2 | 2.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.2 | 4.8 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
1.2 | 11.8 | GO:0043495 | protein anchor(GO:0043495) |
1.2 | 12.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.2 | 2.3 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
1.2 | 6.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.1 | 4.6 | GO:0045545 | syndecan binding(GO:0045545) |
1.1 | 20.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.1 | 26.3 | GO:0031489 | myosin V binding(GO:0031489) |
1.1 | 19.4 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
1.1 | 26.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.1 | 5.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.1 | 10.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.1 | 5.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.1 | 6.6 | GO:0005272 | sodium channel activity(GO:0005272) |
1.1 | 1.1 | GO:0070012 | oligopeptidase activity(GO:0070012) |
1.1 | 11.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
1.1 | 3.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
1.1 | 4.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
1.1 | 2.2 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) |
1.1 | 20.5 | GO:0051018 | protein kinase A binding(GO:0051018) |
1.1 | 12.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.1 | 3.2 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
1.1 | 1.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.0 | 5.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
1.0 | 5.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.0 | 2.1 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
1.0 | 8.2 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
1.0 | 15.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.0 | 99.4 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
1.0 | 7.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.0 | 9.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.0 | 11.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
1.0 | 34.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
1.0 | 4.0 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.0 | 4.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.0 | 7.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.0 | 5.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.0 | 1.0 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
1.0 | 6.8 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
1.0 | 28.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
1.0 | 1.0 | GO:0005522 | profilin binding(GO:0005522) |
1.0 | 2.9 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
1.0 | 3.8 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.0 | 10.5 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.9 | 6.6 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.9 | 2.8 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.9 | 8.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.9 | 51.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.9 | 23.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.9 | 1.9 | GO:0030911 | TPR domain binding(GO:0030911) |
0.9 | 17.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.9 | 4.5 | GO:0033691 | sialic acid binding(GO:0033691) |
0.9 | 2.7 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.9 | 2.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.9 | 8.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.9 | 4.5 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.9 | 0.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.9 | 18.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.9 | 3.5 | GO:0005168 | neurotrophin TRK receptor binding(GO:0005167) neurotrophin TRKA receptor binding(GO:0005168) |
0.9 | 5.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.9 | 39.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.9 | 1.7 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.9 | 112.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.9 | 2.6 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.8 | 2.5 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.8 | 3.4 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.8 | 5.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.8 | 10.8 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.8 | 5.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.8 | 9.1 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.8 | 2.5 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.8 | 18.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.8 | 2.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.8 | 25.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.8 | 10.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.8 | 3.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.8 | 2.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.8 | 11.3 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.8 | 3.2 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.8 | 2.4 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.8 | 6.4 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.8 | 3.2 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.8 | 5.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.8 | 6.9 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.8 | 2.3 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.8 | 5.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.8 | 12.9 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.8 | 9.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.7 | 2.2 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.7 | 7.5 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.7 | 14.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.7 | 2.2 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.7 | 38.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.7 | 5.9 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.7 | 59.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.7 | 6.6 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.7 | 2.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.7 | 4.4 | GO:0089720 | caspase binding(GO:0089720) |
0.7 | 5.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.7 | 7.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.7 | 7.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.7 | 0.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 8.0 | GO:0005536 | glucose binding(GO:0005536) |
0.7 | 2.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.7 | 1.4 | GO:0071253 | connexin binding(GO:0071253) |
0.7 | 5.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.7 | 11.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.7 | 2.8 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.7 | 2.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.7 | 2.1 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.7 | 11.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.7 | 4.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.7 | 4.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.7 | 1.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.7 | 33.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.7 | 2.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.7 | 4.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.7 | 3.4 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.7 | 12.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.7 | 169.0 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.7 | 5.2 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.7 | 3.9 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.7 | 1.3 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.6 | 15.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.6 | 39.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.6 | 4.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.6 | 1.9 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.6 | 2.5 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.6 | 8.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.6 | 0.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.6 | 23.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.6 | 1.8 | GO:0004127 | cytidylate kinase activity(GO:0004127) uridylate kinase activity(GO:0009041) |
0.6 | 8.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.6 | 0.6 | GO:0038132 | neuregulin binding(GO:0038132) |
0.6 | 4.2 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.6 | 1.8 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.6 | 21.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.6 | 2.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.6 | 1.8 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.6 | 2.3 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.6 | 43.3 | GO:0000149 | SNARE binding(GO:0000149) |
0.6 | 1.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.6 | 4.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.6 | 15.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.6 | 5.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.6 | 4.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.6 | 0.6 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.6 | 2.9 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.6 | 1.1 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.6 | 2.9 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.6 | 2.3 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.6 | 2.3 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.6 | 2.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.6 | 14.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.6 | 5.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.6 | 3.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.6 | 3.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.6 | 1.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.6 | 2.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.6 | 18.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.6 | 2.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.6 | 4.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.5 | 2.7 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.5 | 1.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 3.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 102.1 | GO:0008017 | microtubule binding(GO:0008017) |
0.5 | 2.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.5 | 112.5 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.5 | 1.6 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.5 | 2.1 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.5 | 1.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.5 | 1.6 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.5 | 1.0 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.5 | 4.7 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.5 | 0.5 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.5 | 3.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.5 | 0.5 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
0.5 | 1.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.5 | 91.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.5 | 0.5 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.5 | 21.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.5 | 2.0 | GO:0001639 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
0.5 | 2.5 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.5 | 1.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.5 | 42.2 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.5 | 8.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.5 | 0.5 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.5 | 1.4 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.5 | 1.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.5 | 14.1 | GO:0005262 | calcium channel activity(GO:0005262) |
0.5 | 8.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.5 | 8.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.5 | 1.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.5 | 16.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.5 | 3.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.5 | 5.0 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.5 | 3.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.5 | 3.6 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.5 | 0.9 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.5 | 1.4 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.5 | 14.0 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.4 | 0.9 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.4 | 4.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.4 | 5.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.4 | 18.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.4 | 7.4 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.4 | 4.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.4 | 8.2 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.4 | 47.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.4 | 11.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.4 | 0.9 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.4 | 2.5 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 3.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.4 | 0.4 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 2.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 6.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.4 | 1.2 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.4 | 23.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.4 | 4.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) lipoprotein particle receptor binding(GO:0070325) |
0.4 | 6.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.4 | 4.4 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.4 | 9.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.4 | 6.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.4 | 2.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.4 | 3.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 5.0 | GO:0005328 | neurotransmitter transporter activity(GO:0005326) neurotransmitter:sodium symporter activity(GO:0005328) |
0.4 | 3.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.4 | 8.8 | GO:0030552 | cAMP binding(GO:0030552) |
0.4 | 1.1 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.4 | 2.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.4 | 1.1 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.4 | 2.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.4 | 7.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.4 | 4.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.4 | 3.5 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.3 | 1.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 4.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 1.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.3 | 0.7 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.3 | 6.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.3 | 0.7 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.3 | 0.3 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.3 | 7.1 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.3 | 2.5 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.3 | 1.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 7.4 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.3 | 2.7 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 1.8 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 0.9 | GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity(GO:0004482) |
0.3 | 24.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.3 | 0.6 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.3 | 5.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.3 | 1.2 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 1.2 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.3 | 8.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.3 | 18.5 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.3 | 1.4 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.3 | 6.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 5.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 1.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.3 | 0.8 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.3 | 42.2 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.3 | 0.8 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.3 | 2.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.3 | 0.8 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.3 | 1.4 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.3 | 3.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 1.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.3 | 0.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 4.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 0.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.3 | 1.3 | GO:0070330 | aromatase activity(GO:0070330) |
0.3 | 0.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 0.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 0.3 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.3 | 0.8 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 1.6 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.3 | 1.0 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.3 | 2.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.3 | 1.0 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.3 | 1.0 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.3 | 0.8 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.3 | 0.8 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.2 | 0.7 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.2 | 1.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 2.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 1.5 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.2 | 5.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 1.2 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.2 | 0.7 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 1.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 1.2 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.2 | 16.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 7.6 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 1.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 1.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 3.5 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 0.7 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.2 | 0.4 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.2 | 1.1 | GO:0009384 | N-acylmannosamine kinase activity(GO:0009384) |
0.2 | 1.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.6 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.2 | 1.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 1.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 9.2 | GO:0016247 | channel regulator activity(GO:0016247) |
0.2 | 1.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 1.4 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.2 | 3.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.2 | 2.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 2.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 1.1 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.2 | 6.8 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.2 | 2.6 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 4.8 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 0.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 0.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.2 | 1.7 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
0.2 | 0.7 | GO:0043532 | angiostatin binding(GO:0043532) |
0.2 | 3.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 0.9 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 6.9 | GO:0044325 | ion channel binding(GO:0044325) |
0.2 | 0.4 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 6.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 1.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 0.5 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.2 | 0.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 3.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 0.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 0.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 0.3 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 1.3 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 0.3 | GO:0070976 | TIR domain binding(GO:0070976) |
0.2 | 1.7 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 0.3 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 0.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 2.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.7 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.6 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) rRNA (adenine) methyltransferase activity(GO:0016433) |
0.1 | 0.9 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.1 | 1.9 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 1.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.7 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.4 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.1 | 2.1 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 8.2 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 0.3 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.1 | 0.4 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.1 | 0.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 1.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.5 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.1 | 2.2 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.1 | 1.2 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 4.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 5.8 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 1.5 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 1.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 1.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 1.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 2.1 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 1.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.2 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 4.6 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.2 | GO:0019962 | interferon receptor activity(GO:0004904) type I interferon receptor activity(GO:0004905) interferon binding(GO:0019961) type I interferon binding(GO:0019962) |
0.1 | 0.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 4.2 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.4 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.1 | 0.3 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.1 | 1.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.5 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.3 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.1 | 0.3 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.2 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.1 | 0.6 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 1.2 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 2.2 | GO:0072509 | divalent inorganic cation transmembrane transporter activity(GO:0072509) |
0.1 | 0.4 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.1 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 0.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 1.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.4 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.1 | 0.2 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 1.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 6.4 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.1 | 0.4 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.1 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.5 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 1.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 8.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.2 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.1 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 2.8 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.2 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 1.0 | GO:0015631 | tubulin binding(GO:0015631) |
0.0 | 0.0 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.0 | 0.6 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.0 | 0.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.1 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.7 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) glycerol transmembrane transporter activity(GO:0015168) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 53.8 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
2.5 | 44.7 | PID_TCR_RAS_PATHWAY | Ras signaling in the CD4+ TCR pathway |
2.2 | 28.9 | PID_THROMBIN_PAR4_PATHWAY | PAR4-mediated thrombin signaling events |
2.1 | 118.1 | PID_REELIN_PATHWAY | Reelin signaling pathway |
1.8 | 103.9 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
1.7 | 6.9 | ST_IL_13_PATHWAY | Interleukin 13 (IL-13) Pathway |
1.5 | 35.0 | ST_WNT_CA2_CYCLIC_GMP_PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.5 | 15.2 | PID_INTEGRIN_A4B1_PATHWAY | Alpha4 beta1 integrin signaling events |
1.5 | 24.8 | SA_B_CELL_RECEPTOR_COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
1.3 | 11.9 | PID_S1P_S1P4_PATHWAY | S1P4 pathway |
1.3 | 30.3 | PID_IL8_CXCR2_PATHWAY | IL8- and CXCR2-mediated signaling events |
1.3 | 5.0 | PID_INTEGRIN5_PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.2 | 13.6 | PID_ERBB4_PATHWAY | ErbB4 signaling events |
1.2 | 24.4 | ST_INTERLEUKIN_4_PATHWAY | Interleukin 4 (IL-4) Pathway |
1.2 | 20.1 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
1.2 | 8.3 | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.1 | 79.3 | PID_LKB1_PATHWAY | LKB1 signaling events |
1.0 | 15.2 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
1.0 | 11.8 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
0.9 | 6.6 | PID_IFNG_PATHWAY | IFN-gamma pathway |
0.9 | 30.3 | PID_BCR_5PATHWAY | BCR signaling pathway |
0.9 | 36.5 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
0.9 | 12.8 | PID_SYNDECAN_3_PATHWAY | Syndecan-3-mediated signaling events |
0.9 | 6.3 | PID_ALK1_PATHWAY | ALK1 signaling events |
0.8 | 25.2 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
0.8 | 2.5 | ST_GRANULE_CELL_SURVIVAL_PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.8 | 23.3 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
0.8 | 0.8 | PID_IL5_PATHWAY | IL5-mediated signaling events |
0.8 | 21.3 | ST_MYOCYTE_AD_PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.8 | 21.1 | SIG_CHEMOTAXIS | Genes related to chemotaxis |
0.7 | 35.4 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.6 | 37.5 | PID_P75_NTR_PATHWAY | p75(NTR)-mediated signaling |
0.6 | 30.8 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
0.6 | 4.4 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
0.6 | 12.8 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
0.6 | 18.7 | PID_SHP2_PATHWAY | SHP2 signaling |
0.5 | 7.6 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.5 | 9.2 | PID_FOXO_PATHWAY | FoxO family signaling |
0.5 | 10.6 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.5 | 0.5 | PID_S1P_S1P3_PATHWAY | S1P3 pathway |
0.5 | 3.7 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.5 | 7.8 | PID_KIT_PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.5 | 59.8 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.5 | 0.9 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.5 | 11.7 | PID_REG_GR_PATHWAY | Glucocorticoid receptor regulatory network |
0.5 | 7.9 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
0.5 | 20.7 | PID_HNF3A_PATHWAY | FOXA1 transcription factor network |
0.5 | 2.3 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
0.5 | 3.6 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.4 | 28.4 | PID_P53_REGULATION_PATHWAY | p53 pathway |
0.4 | 3.3 | PID_IL2_PI3K_PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 6.0 | PID_PI3KCI_AKT_PATHWAY | Class I PI3K signaling events mediated by Akt |
0.4 | 3.5 | PID_VEGFR1_PATHWAY | VEGFR1 specific signals |
0.4 | 0.7 | ST_GA12_PATHWAY | G alpha 12 Pathway |
0.3 | 5.2 | PID_P38_MKK3_6PATHWAY | p38 MAPK signaling pathway |
0.3 | 2.8 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
0.3 | 3.8 | PID_S1P_META_PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 3.1 | PID_CXCR4_PATHWAY | CXCR4-mediated signaling events |
0.3 | 2.7 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 1.7 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 4.6 | PID_RANBP2_PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.3 | 2.6 | ST_G_ALPHA_I_PATHWAY | G alpha i Pathway |
0.3 | 3.8 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 4.4 | PID_TNF_PATHWAY | TNF receptor signaling pathway |
0.3 | 8.1 | PID_ARF_3PATHWAY | Arf1 pathway |
0.3 | 1.7 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 3.1 | PID_CONE_PATHWAY | Visual signal transduction: Cones |
0.3 | 11.6 | PID_ERBB1_DOWNSTREAM_PATHWAY | ErbB1 downstream signaling |
0.3 | 1.6 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 0.5 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 6.0 | PID_CD8_TCR_PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 3.8 | PID_IL2_1PATHWAY | IL2-mediated signaling events |
0.2 | 0.5 | PID_AR_NONGENOMIC_PATHWAY | Nongenotropic Androgen signaling |
0.2 | 2.5 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 3.2 | PID_PDGFRB_PATHWAY | PDGFR-beta signaling pathway |
0.2 | 6.9 | PID_TGFBR_PATHWAY | TGF-beta receptor signaling |
0.2 | 1.7 | PID_ALK2_PATHWAY | ALK2 signaling events |
0.2 | 4.2 | PID_MET_PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 1.3 | PID_THROMBIN_PAR1_PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 4.2 | PID_NFAT_3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 0.7 | PID_RETINOIC_ACID_PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 1.5 | PID_IL27_PATHWAY | IL27-mediated signaling events |
0.1 | 0.3 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
0.1 | 1.7 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
0.1 | 3.3 | PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 5.6 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.9 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 5.0 | PID_RHOA_REG_PATHWAY | Regulation of RhoA activity |
0.1 | 1.0 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
0.1 | 2.1 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.7 | PID_ARF6_PATHWAY | Arf6 signaling events |
0.1 | 0.7 | PID_FAS_PATHWAY | FAS (CD95) signaling pathway |
0.1 | 9.5 | PID_P53_DOWNSTREAM_PATHWAY | Direct p53 effectors |
0.1 | 0.2 | ST_ADRENERGIC | Adrenergic Pathway |
0.1 | 0.6 | PID_PI3KCI_PATHWAY | Class I PI3K signaling events |
0.1 | 0.3 | ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 2.6 | PID_TELOMERASE_PATHWAY | Regulation of Telomerase |
0.0 | 0.4 | ST_INTEGRIN_SIGNALING_PATHWAY | Integrin Signaling Pathway |
0.0 | 0.5 | PID_RAS_PATHWAY | Regulation of Ras family activation |
0.0 | 0.5 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.4 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.3 | PID_FCER1_PATHWAY | Fc-epsilon receptor I signaling in mast cells |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 28.7 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
3.3 | 139.1 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
3.0 | 18.1 | REACTOME_SOS_MEDIATED_SIGNALLING | Genes involved in SOS-mediated signalling |
3.0 | 39.0 | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
2.9 | 5.9 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
2.8 | 64.0 | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | Genes involved in PKA-mediated phosphorylation of CREB |
2.7 | 35.2 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
2.3 | 81.7 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
2.2 | 33.6 | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
2.2 | 49.1 | REACTOME_ARMS_MEDIATED_ACTIVATION | Genes involved in ARMS-mediated activation |
2.2 | 4.4 | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | Genes involved in Adenylate cyclase activating pathway |
2.2 | 2.2 | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
2.1 | 34.3 | REACTOME_GABA_A_RECEPTOR_ACTIVATION | Genes involved in GABA A receptor activation |
2.0 | 41.9 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
2.0 | 4.0 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
2.0 | 47.7 | REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
1.8 | 37.0 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.8 | 3.7 | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.8 | 12.7 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.8 | 41.2 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.8 | 5.4 | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | Genes involved in Prolonged ERK activation events |
1.7 | 53.8 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.6 | 14.4 | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
1.5 | 4.6 | REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
1.5 | 45.1 | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.4 | 11.3 | REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.4 | 4.2 | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
1.4 | 13.9 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | Genes involved in Acyl chain remodelling of PG |
1.3 | 9.3 | REACTOME_PLC_BETA_MEDIATED_EVENTS | Genes involved in PLC beta mediated events |
1.3 | 19.7 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
1.3 | 8.9 | REACTOME_HS_GAG_DEGRADATION | Genes involved in HS-GAG degradation |
1.3 | 30.3 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
1.3 | 43.9 | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.2 | 5.0 | REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.2 | 13.7 | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
1.2 | 15.8 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.2 | 27.1 | REACTOME_ERK_MAPK_TARGETS | Genes involved in ERK/MAPK targets |
1.1 | 1.1 | REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
1.1 | 13.4 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
1.1 | 24.8 | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
1.0 | 29.6 | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
1.0 | 26.5 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
1.0 | 11.0 | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | Genes involved in Post NMDA receptor activation events |
1.0 | 17.0 | REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.0 | 5.9 | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.9 | 31.8 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
0.9 | 9.1 | REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.9 | 8.1 | REACTOME_PLATELET_SENSITIZATION_BY_LDL | Genes involved in Platelet sensitization by LDL |
0.9 | 0.9 | REACTOME_PD1_SIGNALING | Genes involved in PD-1 signaling |
0.9 | 23.2 | REACTOME_EGFR_DOWNREGULATION | Genes involved in EGFR downregulation |
0.9 | 2.7 | REACTOME_ION_CHANNEL_TRANSPORT | Genes involved in Ion channel transport |
0.9 | 1.7 | REACTOME_DOWNSTREAM_TCR_SIGNALING | Genes involved in Downstream TCR signaling |
0.9 | 6.0 | REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.8 | 19.5 | REACTOME_IL1_SIGNALING | Genes involved in Interleukin-1 signaling |
0.8 | 20.3 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
0.8 | 59.7 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
0.8 | 5.6 | REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.8 | 8.5 | REACTOME_IL_RECEPTOR_SHC_SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.8 | 0.8 | REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.8 | 27.8 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.7 | 25.3 | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.7 | 30.6 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.7 | 6.5 | REACTOME_GLUCOSE_TRANSPORT | Genes involved in Glucose transport |
0.7 | 34.0 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
0.7 | 13.7 | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.7 | 17.6 | REACTOME_CGMP_EFFECTS | Genes involved in cGMP effects |
0.7 | 24.3 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR | Genes involved in Signaling by Robo receptor |
0.7 | 4.7 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
0.6 | 1.9 | REACTOME_SEROTONIN_RECEPTORS | Genes involved in Serotonin receptors |
0.6 | 18.3 | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.6 | 4.3 | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.6 | 18.6 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.6 | 12.8 | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.6 | 0.6 | REACTOME_BOTULINUM_NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.6 | 4.2 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
0.6 | 8.9 | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | Genes involved in Degradation of the extracellular matrix |
0.6 | 3.4 | REACTOME_REGULATION_OF_IFNG_SIGNALING | Genes involved in Regulation of IFNG signaling |
0.6 | 9.0 | REACTOME_SIGNALING_BY_NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.6 | 3.3 | REACTOME_REGULATION_OF_IFNA_SIGNALING | Genes involved in Regulation of IFNA signaling |
0.6 | 12.8 | REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.5 | 4.2 | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | Genes involved in Transport of organic anions |
0.5 | 3.1 | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.5 | 15.2 | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | Genes involved in O-linked glycosylation of mucins |
0.5 | 2.9 | REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR | Genes involved in Signaling by constitutively active EGFR |
0.5 | 14.3 | REACTOME_PEROXISOMAL_LIPID_METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.5 | 4.1 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PC | Genes involved in Acyl chain remodelling of PC |
0.4 | 5.8 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.4 | 2.2 | REACTOME_G_ALPHA1213_SIGNALLING_EVENTS | Genes involved in G alpha (12/13) signalling events |
0.4 | 5.4 | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.4 | 4.1 | REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 42.7 | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.4 | 2.0 | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.4 | 10.2 | REACTOME_REGULATORY_RNA_PATHWAYS | Genes involved in Regulatory RNA pathways |
0.4 | 7.5 | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.4 | 1.1 | REACTOME_OLFACTORY_SIGNALING_PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.4 | 4.8 | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.4 | 4.3 | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.4 | 10.1 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 2.4 | REACTOME_THE_NLRP3_INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.3 | 1.0 | REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_ | Genes involved in Cyclin E associated events during G1/S transition |
0.3 | 0.7 | REACTOME_NOD1_2_SIGNALING_PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 4.0 | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.3 | 2.6 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 12.0 | REACTOME_RNA_POL_III_TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.3 | 7.7 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 2.7 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 8.6 | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 6.8 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 2.6 | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 18.5 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.3 | 2.2 | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | Genes involved in SLC-mediated transmembrane transport |
0.3 | 1.9 | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 4.4 | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 1.3 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.3 | 2.6 | REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.3 | 23.5 | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.3 | 6.0 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
0.3 | 2.0 | REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 0.5 | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.2 | 57.9 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 1.6 | REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 8.1 | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 1.4 | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 1.3 | REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.2 | 3.1 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 4.4 | REACTOME_PERK_REGULATED_GENE_EXPRESSION | Genes involved in PERK regulated gene expression |
0.2 | 1.9 | REACTOME_ER_PHAGOSOME_PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 1.6 | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 4.0 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 3.2 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 0.6 | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 0.6 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.2 | 0.2 | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 1.1 | REACTOME_MTORC1_MEDIATED_SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 1.9 | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 1.7 | REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.2 | 3.8 | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 3.3 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 1.1 | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 6.9 | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.1 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.8 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 3.3 | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 4.1 | REACTOME_REGULATION_OF_INSULIN_SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 0.5 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.0 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 1.4 | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 5.0 | REACTOME_POTASSIUM_CHANNELS | Genes involved in Potassium Channels |
0.1 | 0.2 | REACTOME_SIGNALLING_TO_RAS | Genes involved in Signalling to RAS |
0.1 | 1.2 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 2.6 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.7 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 2.0 | REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 0.2 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.7 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.5 | REACTOME_METAL_ION_SLC_TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.5 | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 2.1 | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.0 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.3 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.1 | REACTOME_IRON_UPTAKE_AND_TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.3 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.1 | REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |